Search results for " POLYMERIC NANOPARTICLES"

showing 5 items of 5 documents

Polyaspartamide-g-Polylactide graft cpolymers able to form nanoparticles obtained by a novel synthetic strategy.

2009

GRAFT COPOLYMERS POLYMERIC NANOPARTICLES POLY(LACTIC ACID)Settore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct

Polyaspartamide-based nanoparticles loaded with fluticasone propionate and the in vitro evaluation towards cigarette smoke effects

2017

This paper describes the evaluation of polymeric nanoparticles (NPs) as a potential carrier for lung administration of fluticasone propionate (FP). The chosen polymeric material to produce NPs was a copolymer based on α,β-poly(N-2-hydroxyethyl)-d,l-aspartamide (PHEA) whose backbone was derivatised with different molecules, such as poly(lactic acid) (PLA) and polyethylenglycol (PEG). The chosen method to produce NPs from PHEA-PLA-PEG2000 was the method based on high-pressure homogenization and subsequent solvent evaporation by adding Pluronic F68 during the process and trehalose before lyophilisation. Obtained colloidal FP-loaded NPs showed a slightly negative surface charge and nanometric d…

Materials scienceFluticasone propionate (FP)General Chemical EngineeringNanoparticle02 engineering and technologyPolymeric nanoparticle010402 general chemistry01 natural sciencesαβ-poly-(N-2-hydroxyethyl)-DL-aspartamide (PHEA)Articlealpha beta-poly-(N-2-hydroxyethyl)-D L-aspartamide (PHEA)">dPoly(lactic acid) (PLA)lcsh:ChemistryColloidchemistry.chemical_compoundPEG ratioCopolymer?Organic chemistryGeneral Materials ScienceSurface charge?-poly-(N-2-hydroxyethyl)-dαβ-poly-(N-2-hydroxyethyl)-technology industry and agriculture">l-aspartamide (PHEA)Poly(ethylene glycol) (PEG)respiratory system021001 nanoscience & nanotechnologyTrehaloseIn vitro0104 chemical sciencesLactic acidαβ-poly-(<i>N</i>-2-hydroxyethyl)-<span style="font-variant: small-caps;">d</span><span style="font-variant: small-caps;">l</span>-aspartamide (PHEA); poly(lactic acid) (PLA); poly(ethylene glycol) (PEG); polymeric nanoparticles; fluticasone propionate (FP)polymeric nanoparticleschemistrylcsh:QD1-999l-aspartamide (PHEA); poly(lactic acid) (PLA); poly(ethylene glycol) (PEG); polymeric nanoparticles; fluticasone propionate (FP)0210 nano-technologyNuclear chemistry
researchProduct

Margination of Fluorescent Polylactic Acid-Polyaspartamide based Nanoparticles in Microcapillaries In Vitro: the Effect of Hematocrit and Pressure.

2017

The last decade has seen the emergence of vascular-targeted drug delivery systems as a promising approach for the treatment of many diseases, such as cardiovascular diseases and cancer. In this field, one of the major challenges is carrier margination propensity (i.e., particle migration from blood flow to vessel walls); indeed, binding of these particles to targeted cells and tissues is only possible if there is direct carrier–wall interaction. Here, a microfluidic system mimicking the hydrodynamic conditions of human microcirculation in vitro is used to investigate the effect of red blood cells (RBCs) on a carrier margination in relation to RBC concentration (hematocrit) and pressure drop…

Pharmaceutical ScienceNanoparticle02 engineering and technologyPolymeric nanoparticleHematocrit01 natural sciencesAnalytical Chemistrychemistry.chemical_compoundDrug Delivery SystemsPolylactic acidDrug Discoveryαβ-poly-(N-2-hydroxyethyl)-dl-aspartamide (PHEA)medicine.diagnostic_testMolecular StructureChemistry">l-aspartamide (PHEA)poly(ethylene glycol) (PEG)Microfluidic Analytical Techniques021001 nanoscience & nanotechnologypolymeric nanoparticlesBiochemistryHematocritmarginationChemistry (miscellaneous)Drug deliveryMolecular Medicine0210 nano-technologyDrug carrier">PolyestersIn Vitro Techniquesα β-poly-(N-2-hydroxyethyl)-D010402 general chemistryFluorescenceArticleMicrocirculationαβ-poly-(N-2-hydroxyethyl)-<span style="font-variant: small-caps;">d</span><span style="font-variant: small-caps;"></span><span style="font-variant: small-caps;">l</span>-aspartamide (PHEA); poly(lactic acid) (PLA); poly(ethylene glycol) (PEG); polymeric nanoparticles; marginationlcsh:QD241-441Rhodaminelcsh:Organic chemistrypoly(lactic acid) (PLA)PEG ratiomedicineHumansPhysical and Theoretical ChemistryParticle Sizeα β-poly-(N-2-hydroxyethyl)-DL-aspartamide (PHEA)αβ-poly-(N-2-hydroxyethyl)-RhodaminesMicrocirculationOrganic Chemistry0104 chemical sciencesBiophysicsNanoparticles">dPeptidesMolecules (Basel, Switzerland)
researchProduct

HYDROPHOBIC POLYMER COATED SUPERPARAMAGNETIC NANOPARTICLES FOR ANTICANCER DRUG DELIVERY

2011

HYDROPHOBIC POLYMER COATED SUPERPARAMAGNETI NANOPARTICLES FOR ANTICANCER DRUG DELIVERY LICCIARDI M.1, SCIALABBA C.1, AMATO G.1, CAVALLARO G.1, GIAMMONA G.1,2 1Dipartimento di Scienze e Tecnologie Molecolari e Biomolecolari (STEMBIO), University of Palermo, via Archirafi 32, 90123, Palermo, Italy. 2IBF-CNR, via Ugo La Malfa, 153, 90143 Palermo, Italy. Superparamagnetic Fe3O4 nanoparticles have been recently used in drug delivery applications [1-4]. In this study, a novel approach to prepare magnetic polymeric nanoparticles containing superparamagnetic domains and hydrophobic polymeric shell using microemulsion-solvent evaporation method is reported. PHEA-IB-poly(ButMA) copolymer was used as …

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoFERROMAGNETIC POLYMERIC NANOPARTICLES
researchProduct

LIPID AND POLYMERIC NANOSTRUCTURES FOR BRAIN DRUG DELIVERY AND TARGETING

2009

Settore CHIM/09 - Farmaceutico Tecnologico Applicativolipid nanoparticles polymeric nanoparticles brain targeting
researchProduct